Edoxaban Tosylate
Tablet,Tilm coated : 60 mg, 30 mg, and 15 mg
Edoxaban Tosylate Tablet is a factor Xa inhibitor indicated:
To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF)
Limitation of Use for NVAF
Edoxaban Tosylate Tablet should not be used in patients with creatinine clearance (CrCL) > 95 mL/min because of increased risk of ischemic stroke compared to warfarin at the highest dose studied (60 mg) SAVAYSA is indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5 to 10 days of initial therapy with a parenteral anticoagulant.
Previous:Nothing
Next:Nothing